CLINICAL_TRIALS
trial_result
· 2020-06-11
Clinical Trial Update: Efficacy and Tolerability of Erenumab in the Management of Persistent Redness and Flushing in Rosacea [Phase 2]
Summary
Phase 2 trial exploring efficacy and tolerability of erenumab for persistent redness and flushing in rosacea.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Messoud Ashina | Conditions: Rosacea | Phase 2 | Status: UNKNOWN